Ireland Digestive System Disorder Medicine Sales is set to reach $224 Million by 2026 from $252.1 Million, is expected to be up 1.6% per year. Since 2017, the market was up 3.9% year on year attaining $36,680 Million. Japan, South Korea and Canada respectively came in numbers 2, 3 and 4 in this ranking.
How does Ireland perform in Digestive System Disorder?
Forecast: Alimentary Tract and Metabolism Medicine Sales in Ireland
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Ireland
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Ireland
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Ireland
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Sales in Ireland
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Ireland
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Ireland
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Ireland
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in Ireland
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Standardised Death Rate Caused by Chronic Liver Disease, by Sex and Age in Ireland
- Units (Deaths) Per Hundred Thousand Persons, Standardised Rates
- 2024 to 2028
- ReportLinker Research